Anthem Biosciences Peer Comparison

NSE: ANTHEM | BSE: 544449

₹881.90

₹-9.80 (-1.10%)

As on 23-Sep-2026IST

Market cap

₹49,700 Cr

Revenue (TTM)

₹2,002 Cr

P/E Ratio

86.3

P/B Ratio

15.9

Div. Yield

0.2 %

Edit

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Market cap (₹ Cr)	49,700	2,725	189	155	1,02,446
Revenue (₹ Cr)	2,002	419	--	71	8,712
Net Profit (₹ Cr)	575.95	79.66	-0.86	5.14	1,457.40
Net Margin (%)	26.66	18.53	-2,391.67	7.16	16.41
RoE (%)	20.48	18.52	-3.56	5.85	14.39
Price to Earnings	86.29	34.21	--	44.36	70.32
Price-To-Book	15.88	5.79	4.75	2.12	9.37

Income Statement (₹ Cr)

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Operating Revenue	2,124.33	407.29	--	46.84	8,373.45
Total Income	2,280.12	416.28	3.67	47.52	8,538.02
Total Expenditure	1,290.36	265.77	0.16	39.30	6,132.57
EBITDA	833.97	141.52	-0.16	7.55	2,240.88
Depreciation	134.07	43.77	--	6.25	446.53
EBIT	699.90	97.75	-0.16	1.29	1,794.35
Interest	7.06	1.17	--	1.92	235.10
Other Income	155.78	8.99	3.67	0.68	164.57
Exceptional Items	-24.39	-1.62	--	--	-48.24
Profit before Tax	824.24	103.95	3.50	0.05	1,675.58
Provision for Tax	232.45	26.44	--	-0.01	233.17
Profit after Tax	591.79	77.51	3.50	0.06	1,442.41

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Shareholder's Funds	3,042.52	456.87	8.53	49.94	10,746.63
Minority Interest	--	--	--	0.13	--
Non-Current Liabilities	33.74	33.55	--	15.23	4,250.88
Current Liabilities	529.71	65.52	0.30	12.07	2,186.94
Total Liabilities	3,633.29	562.23	8.84	78.29	17,184.45

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Non-Current Assets	1,598.82	331.07	--	48.61	15,239.66
Current Assets	2,007.15	224.87	8.84	28.76	1,944.79
Total Assets	3,633.29	562.23	8.84	78.29	17,184.45
Total Debt*	51.07	3.33	0.00	15.14	2,906.82
Net Current Assets	1,477.43	159.35	8.53	16.69	-242.15
Contingent Liabilities	90.20	1.95	--	--	934.37

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Cash From Operating Activities	844.49	147.14	0.00	10.07	1,633.32
Cash Flow from Investing Activities	-701.62	-129.67	--	-15.62	-1,688.99
Cash from Financing Activities	-40.00	-10.35	--	5.24	59.27
Net Cash Inflow / Outflow	102.87	7.12	0.00	-0.30	3.60

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
ROCE (%)	29.62	24.81	51.69	3.17	14.97
ROE (%)	21.98	18.87	51.69	0.14	14.53
ROA (%)	18.06	15.25	49.91	0.08	8.91
EBIT Margin (%)	46.59	36.95	--	17.55	28.73
Net Margin (%)	25.95	18.62	95.57	0.12	16.89
Cash Profit Margin (%)	33.25	29.78	--	13.47	22.56

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Revenue Growth (%)	15.17	18.40	--	18.14	19.14
EBIT Growth (%)	30.79	19.27	192.30	53.88	20.01
Net Profit Growth (%)	31.14	16.11	192.29	104.45	34.07
EPS Growth (%)	30.53	15.59	192.29	109.10	33.93
Book Value Growth (%)	26.67	20.79	69.71	1.09	14.45

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Price / Earnings	62.29	21.95	6.80	526.25	64.88
Price / Book Value	12.25	3.78	2.79	1.45	8.83
Dividend Yield (%)	0.30	0.53	0.00	0.00	0.21
EV/EBITDA	37.02	10.89	6.80	9.54	39.82
Market Cap (₹ Cr)	36,865.25	1,701.05	--	63.50	93,580.84

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Debt to Equity	0.02	0.01	0.00	0.34	0.27
Short term debt to equity ratio	0.00	--	--	0.02	0.01
Current Ratio	3.79	3.43	29.18	2.38	0.89
Quick Ratio	3.55	2.97	29.18	2.25	0.84
Interest Coverage	117.83	90.08	--	1.03	8.13

	Anthem Biosciences	Vimta Labs	Genesis IBRC India	Jeevan Scientific	Max Healthcare
Debtors to sales (%)	27.80	25.95	--	34.03	11.58
Asset Turnover	0.67	0.80	0.00	0.65	0.52
Receivable days	87.02	94.97	--	110.00	36.12
Inventory Days	38.87	24.65	--	10.55	4.81
Payable days	41.63	--	--	255.53	169.18
Cash Conversion Cycle	84.26	--	--	-134.98	-128.26

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.